Summary: Listen to the Below the Line podcast, where MAPS Founder and Executive Director Rick Doblin, Ph.D., speaks with James Beshara about the long journey MAPS has undergone to publish the successful results of our first Phase 3 study involving the treatment of PTSD with MDMA-assisted therapy, and the long road that lies ahead until psychedelics are responsibly integrated into society.
Originally appearing here.
